Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the Listing Regulations, Valiant Laboratories has informed that the Board of Directors of the Company, at its meeting held on Thursday, September 17, 2026, has approved the proposed acquisition and holding of shares in AMPYR Renewable Energy Resources Twelve A (‘AMPYR’), for an aggregate consideration not exceeding ?70,00,000/-, for availing renewable energy under a group captive open access arrangement; in a manner as may be outlined in the definitive agreements to be executed with AMPYR. The details as required under Regulation 30 read with Para A of Part A of Schedule III of the Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026 are enclosed as ‘Annexure-A’. The meeting of the Board of Directors commenced at 11:41 AM and concluded at 12:01 PM. This intimation is also being uploaded on the Company’s website at www.valiantlabs.in.
The above information is a part of company’s filings submitted to BSE.
